Skip to main content
. 2016 Sep 6;23(9):757–766. doi: 10.1128/CVI.00071-16

TABLE 4.

Results of visit-specific ROC curve analysisa

Visit Cutoff (pg/ml) Area under the curve Sensitivity (%) Specificity (%) Relative risk (95% CI)
Acute phase, pretreatment 186.17 0.60 55 54 1.33 (0.44–4.00)
Posttreatment follow-up 100.58 0.79 64 68 3.00 (0.96–9.35)
1-mo follow-up 111.67 0.85 82 83 12.60 (2.97–53.43)
3-mo follow-up 114.12 0.77 73 74 5.44 (1.58–18.75)
6-mo follow-up 104.94 0.76 64 65 2.68 (0.86–8.38)
1-yr follow-up 91.36 0.83 55 74 2.77 (0.94–8.15)
a

The area under the curve, sensitivity, specificity, and relative risk of development of PTLDS are shown for each visit using cutoffs identified as the intersection of the sensitivity and specificity plots (not shown).